Azerbaijan, Baku, Sept. 29/ Trend M. Moezzi
Iranian researchers have succeeded in domestically producing a medicament for treating osteoporosis.
Clinical studies of the medicament were conducted over the last year at Tehran University of Medical Sciences' Shariati Hospital, the Iranian Students' News Agency (ISNA) reports.
The medicament, Cinnoppar TM, will cost 30 percent less than its foreign-made version which costs around $1,000.
The medicament's molecular structure resembles that of the parathyroid hormone (PTH) which is one of two hormones that control calcium levels in the body. Calcium is essential for stronger bones.
Osteoporosis is one of the most prevalent diseases among elderly Iranians. It affects one of four Iranian women older 50 and 90 percent of those older 75.